2024 annual financial data
Enanta Pharmaceuticals 2024 Operating margin
Enanta Pharmaceuticals 2024 operating margin with verified reported values.
Direct answer
Operating margin was -179.92%.
Operating income was -121,691,000 USD and net income was -116,045,000 USD.
Operating cash flow was -78,764,000 USD.
Get free Enanta Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 67,635,000 USD
- Operating income
- -121,691,000 USD
- Net income
- -116,045,000 USD
- Operating cash flow
- -78,764,000 USD